Osterweis Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Osterweis Capital Management's RGEN Position: Q1 2026 in Review
Osterweis Capital Management increased its Repligen (RGEN) stake by 69% in Q1 2026, buying an estimated $5.25M and bringing the position to 92,220 shares worth $10.9M. The position accounts for 0.56% of the portfolio, ranked #56.
Osterweis Capital Management first reported a position in RGEN in Q2 2024 and has held it in 7 quarters since. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Osterweis Capital Management held 92,220 shares of Repligen worth $10.9M as of Q1 2026.
- Osterweis Capital Management bought 37,585 Repligen shares in Q1 2026, an estimated $5.25M.
- Repligen made up 0.56% of Osterweis Capital Management's portfolio in Q1 2026, its #56 holding.
- Osterweis Capital Management first reported a position in Repligen in Q2 2024 and has held it in 7 quarters since.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Osterweis Capital Management's 13F filing for Q1 2026, filed 15 May 2026.